Close Menu

NEW YORK – Bio-Rad Laboratories said after the close of the market Thursday that its third quarter revenues increased 15 percent year over year driven by COVID-19-related gains in its PCR and digital PCR businesses.

For the three months ended Sept. 30, Bio-Rad reported revenues of $647.3 million compared to $560.6 million a year ago, well ahead of analysts' average estimate of $570.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.